Company intelligence / Profile preview

Fujian Wanke Pharmaceutical

Sanming, Fujian, China

Ownership: Private
Employees: ~200
Development stage: Other

Overview

Fujian Wanke Pharmaceutical is a China-based pharmaceutical company focused on the development and production of high-quality Active Pharmaceutical Ingredients (APIs) and finished drug products. The company specializes in anti-viral therapies, particularly for the treatment of chronic Hepatitis B, and cardiovascular medications such as statins. Located in the Shaxian High-tech Industrial Park in Fujian Province, the firm operates GMP-compliant manufacturing lines. Its core product offerings include Entecavir, Tenofovir Disoproxil Fumarate, and Rosuvastatin Calcium, serving both the Chinese domestic market and global pharmaceutical supply chains.

Therapeutic areas: CardiovascularInfectious Diseases
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Fujian Wanke Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fujian Wanke Pharmaceutical.

Explore the full profile